“Classical 3 + 3 design”versus“accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents
Nicolas Penel, Nicolas Isambert, Pierre Leblond, Charles Ferte, Alain Duhamel, Jacques BonneterreVolume:
27
Language:
english
Pages:
5
DOI:
10.1007/s10637-008-9213-5
Date:
December, 2009
File:
PDF, 100 KB
english, 2009